CEST-MRI detects metabolite levels altered by breast cancer cell aggressiveness and chemotherapy response

Research output: Journal Publications and Reviews (RGC: 21, 22, 62)21_Publication in refereed journalpeer-review

35 Scopus Citations
View graph of relations

Author(s)

  • Lu Jiang
  • Menglin Cheng
  • Jannie P. Wijnen
  • Guanshu Liu
  • Peng Huang
  • Peter C. M. van Zijl
  • Michael T. Mcmahon
  • Kristine Glunde

Detail(s)

Original languageEnglish
Pages (from-to)806-816
Journal / PublicationNMR in Biomedicine
Volume29
Issue number6
Publication statusPublished - 1 Jun 2016
Externally publishedYes

Abstract

Chemical exchange saturation transfer (CEST) is an MRI contrast mechanism that detects the exchange of protons from distinct hydroxyl, amine, and amide groups to tissue water through the transfer of signal loss, with repeated exchange enhancing their effective signal. We applied CEST to detect systematically 15 common cellular metabolites in a panel of differentially aggressive human breast cancer cell lines. The highest CEST contrast was generated by creatine, myo-inositol, glutamate, and glycerophosphocholine, whose cellular concentrations decreased with increasing breast cancer aggressiveness. These decreased metabolite concentrations resulted in turn in a decreased CEST profile with increasing breast cancer aggressiveness in water-soluble extracts of breast cell lines. Treatment of both breast cancer cell lines with the chemotherapy drug doxorubicin resulted in increased metabolic CEST profiles, which correlated with significant increases in creatine, phosphocreatine, and glycerophosphocholine. CEST can detect breast cancer aggressiveness and response to chemotherapy in water-soluble extracts of breast cell lines. The presented results help shed light on possible contributions from CEST-active metabolites to the CEST contrast produced by breast cancers. The metabolic CEST profile may improve detection sensitivity over conventional MRS, and may have the potential to assess breast cancer aggressiveness and response to chemotherapy non-invasively using MRI if specialized metabolic CEST profile detection can be realized in vivo.

Research Area(s)

  • Breast cancer, Cells, CEST, Chemotherapy, Metabolism, Metabolites

Citation Format(s)

CEST-MRI detects metabolite levels altered by breast cancer cell aggressiveness and chemotherapy response. / Chan, Kannie W. Y.; Jiang, Lu; Cheng, Menglin; Wijnen, Jannie P.; Liu, Guanshu; Huang, Peng; van Zijl, Peter C. M.; Mcmahon, Michael T.; Glunde, Kristine.

In: NMR in Biomedicine, Vol. 29, No. 6, 01.06.2016, p. 806-816.

Research output: Journal Publications and Reviews (RGC: 21, 22, 62)21_Publication in refereed journalpeer-review